Closing the gap: PATROL’s approach to overcoming lung cancer diagnostic inequality

A non-invasive, low-cost lung cancer detection platform called PATROL.

Medical devices makers are trying to take a page from Uber’s playbook

In a recent survey of U.S. companies, medical device makers reported spending $31 million on average to bring a new product to market under the

March 22, 2024

With new data, Regenxbio advances plan for Duchenne gene therapy

Regenxbio said Thursday that its experimental gene therapy for Duchenne muscular dystrophy was administered to two more boys and produced high levels of a miniaturized

August 1, 2024

Women on the Pill Have Comforting CVD Outcomes Years Down the Line

Reassuringly, a history of oral contraceptive use had no deleterious effects on cardiovascular disease (CVD) and survival over long-term follow-up, a U.K. Biobank study showed.

August 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.